Famous Case Histories In Neurotrauma

Using a popular case history format, this book presents a scientific history of neurotrauma. It covers a range of well-known cases, including Roald Dahl, James Brady, and Walter Freeman to give insights into a variety of neurotrauma causes and effects, from aphasia and amnesia to lobotomy and mercury toxicity. Cases are connected to clinical research methods, exploring how these methods have changed over time and illustrating how these cases are still relevant as we continue to learn about recovery from brain and spinal cord injuries. Focusing on individuals who survived their injuries beyond the acute phase, the book highlights the long-term behavioral effects of the injuries and provides estimates for prognoses and recovery pathways in acknowledgment of naturally occurring neuroregeneration. With helpful key term definitions, Matyas distinguishes fact from fiction to give an accurate account of a wide spectrum of cases and highlight what we can learn from them. Famous Case Histories in Neurotrauma is valuable reading for students in behavioral neuroscience, clinical neuropsychology and related fields.

Traumatic brain injury (TBI) remains a significant source of death and permanent disability, contributing to nearly one-third of all injury related deaths in the United States and exacting a profound personal and economic toll. Despite the increased resources that have recently been brought to bear to improve our understanding of TBI, the development of new diagnostic and therapeutic approaches has been disappointingly slow. Translational Research in Traumatic Brain Injury attempts to integrate expertise from across specialties to address knowledge gaps in the field of TBI. Its chapters cover a wide scope of TBI research in five broad areas: Epidemiology Pathophysiology Diagnosis Current treatment strategies and sequelae Future therapies Specific topics discussed include the societal impact of TBI in both the civilian and military populations, neurobiology and molecular mechanisms of axonal and neuronal injury, biomarkers of traumatic brain injury and their relationship to pathology, neuroplasticity after TBI, neuroprotective and neurorestorative therapy, advanced neuroimaging of mild TBI, neurocognitive and psychiatric symptoms following mild TBI, sports-related TBI, epilepsy and PTSD following TBI, and more. The book integrates the perspectives of experts across disciplines to assist in the translation of new ideas to clinical practice and ultimately to improve the care of the brain injured patient.

This is a clinically accessible reference guide to acquired brain injuries (ABIs) that provides medical and nonmedical healthcare professionals who work with patients in brain trauma and rehabilitation settings with easily understandable information about this population. It provides physicians, psychologists, social workers, counselors, nurses, other allied health professionals, and particularly trainees with short clinical synopses of a full range of ABIs, from causes through diagnoses and treatment. Written by expert authors, the resource summarizes knowledge on the most prevalent ABIs in a clear, consistent format including overview, etiology, epidemiology, clinical presentation (including cognitive, emotional, behavioral, and sensorimotor), diagnostic considerations, evidence-based treatments, prognosis, and an illustrative case study. Psychosocial considerations for ABI patients, an important component of care, are also addressed. Key Features: Delivers information in a concise, quick reference format Written in accessible language Informs a wide range of healthcare professionals and trainees Covers a full gamut of ABIs Authored by recognized experts in the field

Expanding both the conceptual and clinical knowledge base on the subject, the Third Edition of Detection of Malingering during Head Injury Litigation offers the latest detection tools and techniques for veteran and novice alike. Increased public awareness of traumatic brain injuries has fueled a number of significant developments: on the one hand, more funding and more research related to these injuries and their resulting deficits; on the other, the possibility of higher stakes in personal injury suits—and more reasons for individuals to feign injury. As in its earlier editions, this practical revision demonstrates how to combine clinical expertise, carefully-gathered data, and the use of actuarial models as well as common sense in making sound evaluations and reducing ambiguous results. The book navigates the reader through the many caveats that come with the job, beginning with the scenario that an individual may be malingering despite having an actual brain injury. Among the updated features: Specific chapters on malingering on the Word Memory Test (WMT), Test of Malingered Memory (TOMM) MMPI-2, MMPI-RF and MMPI-3; Detailed information regarding performance on performance validity tests in the domain of executive functioning and memory, Guidelines for explaining performance and symptom validity testing to the trier of fact; Chapters on mild TBI in children in head injury litigation, cultural concerns and ethical issues in the context of head injury litigation.

Neuroimmune pharmacology seeks to harness the immune system to provide pharmacological intervention to combat neurodegenerative diseases. This book provides a comprehensive overview of topics that embrace the link between the immune system and the pathogenesis of neurodegenerative disorders. Results from recent studies strongly suggest that a major part of the process in diseases including Alzheimer’s and Parkinson’s as well as Prion diseases, comes from changes in the innate and adaptive arms of the brain and peripheral immune systems. Thus, the book provides an in-depth study of numerous fields including immunology, pharmacology, neuroscience and neurovirology. It is accompanied by a CD-ROM that includes access to lectures, slide presentations, and question and answers on neuroimmune pharmacology.